LINC01089, suppressed by YY1, inhibits lung cancer progression by targeting miR-301b-3p/HPDG axis.

Yang, Rusong; Liu, Zhengcheng; Cao, Hui; Shi, Ye

Yang, Rusong; Liu, Zhengcheng; Cao, Hui; Shi, Ye.

Afiliação

Yang R; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanjing Medical University, No.121 Jiangjiayuan Road, Gulou District, Nanjing, Jiangsu, 210011, People's Republic of China. rusongyangmedical@163.com.
Liu Z; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanjing Medical University, No.121 Jiangjiayuan Road, Gulou District, Nanjing, Jiangsu, 210011, People's Republic of China.
Cao H; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanjing Medical University, No.121 Jiangjiayuan Road, Gulou District, Nanjing, Jiangsu, 210011, People's Republic of China.
Shi Y; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanjing Medical University, No.121 Jiangjiayuan Road, Gulou District, Nanjing, Jiangsu, 210011, People's Republic of China.

Cell Biol Toxicol ; 38(6): 1063-1077, 2022 12.

Article em En | MEDLINE | ID: mdl-34561789

Assuntos

Neoplasias Pulmonares; MicroRNAs; RNA Longo não Codificante; Humanos; Linhagem Celular Tumoral; Movimento Celular/genética; Proliferação de Células/genética; Regulação Neoplásica da Expressão Gênica/genética; Neoplasias Pulmonares/patologia; MicroRNAs/genética; MicroRNAs/metabolismo; Fator de Transcrição YY1/genética; Fator de Transcrição YY1/metabolismo; RNA Longo não Codificante/genética

Palavras-chave

HPGD; LINC01089; Lung cancer; Tumorigenesis; YY1; miR-301b-3p

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google